BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17996332)

  • 1. Phosphorylation-dependent structure of ATF4 peptides derived from a human ATF4 protein, a member of the family of transcription factors.
    Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Benarous R; Girault JP
    Peptides; 2007 Dec; 28(12):2253-67. PubMed ID: 17996332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-catenin.
    Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Tanchou V; Benarous R; Girault JP
    Biochemistry; 2008 Jan; 47(1):14-29. PubMed ID: 18052253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP.
    Coadou G; Gharbi-Benarous J; Megy S; Bertho G; Evrard-Todeschi N; Segeral E; Benarous R; Girault JP
    Biochemistry; 2003 Dec; 42(50):14741-51. PubMed ID: 14674748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP.
    Evrard-Todeschi N; Gharbi-Benarous J; Bertho G; Coadou G; Megy S; Benarous R; Girault JP
    Peptides; 2006 Jan; 27(1):194-210. PubMed ID: 16165251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of the phosphorylation motif of the HIV-1 protein Vpu bound to the selective monoclonal antibody using TRNOESY and STD NMR spectroscopy.
    Gharbi-Benarous J; Bertho G; Evrard-Todeschi N; Coadou G; Megy S; Delaunay T; Benarous R; Girault JP
    Biochemistry; 2004 Nov; 43(46):14555-65. PubMed ID: 15544326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of a peptide derived from the oncogenic protein beta-Catenin in its phosphorylated and nonphosphorylated states.
    Megy S; Bertho G; Gharbi-Benarous J; Baleux F; Benarous R; Girault JP
    Peptides; 2005 Feb; 26(2):227-41. PubMed ID: 15629534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural studies on 24P-IkappaBalpha peptide derived from a human IkappaB-alpha protein related to the inhibition of the activity of the transcription factor NF-kappaB.
    Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Sonois V; Benarous R; Girault JP
    Biochemistry; 2007 Mar; 46(11):2958-72. PubMed ID: 17319651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STD and TRNOESY NMR studies on the conformation of the oncogenic protein beta-catenin containing the phosphorylated motif DpSGXXpS bound to the beta-TrCP protein.
    Megy S; Bertho G; Gharbi-Benarous J; Evrard-Todeschi N; Coadou G; Ségéral E; Iehle C; Quéméneur E; Benarous R; Girault JP
    J Biol Chem; 2005 Aug; 280(32):29107-16. PubMed ID: 15927956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FWD1/beta-TrCP-mediated degradation pathway establishes a 'turning off switch' of a Cdc42 guanine nucleotide exchange factor, FGD1.
    Hayakawa M; Kitagawa H; Miyazawa K; Kitagawa M; Kikugawa K
    Genes Cells; 2005 Mar; 10(3):241-51. PubMed ID: 15743413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase.
    Lassot I; Ségéral E; Berlioz-Torrent C; Durand H; Groussin L; Hai T; Benarous R; Margottin-Goguet F
    Mol Cell Biol; 2001 Mar; 21(6):2192-202. PubMed ID: 11238952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways.
    Watanabe N; Arai H; Iwasaki J; Shiina M; Ogata K; Hunter T; Osada H
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11663-8. PubMed ID: 16085715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the complex between phosphorylated substrates and the SCF beta-TrCP ubiquitin ligase receptor: a combined NMR, molecular modeling, and docking approach.
    Evrard-Todeschi N; Pons J; Gharbi-Benarous J; Bertho G; Benarous R; Girault JP
    J Chem Inf Model; 2008 Dec; 48(12):2350-61. PubMed ID: 19053519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into tyrosine phosphorylation control of protein-protein association from the NMR structure of a band 3 peptide inhibitor bound to glyceraldehyde-3-phosphate dehydrogenase.
    Eisenmesser EZ; Post CB
    Biochemistry; 1998 Jan; 37(3):867-77. PubMed ID: 9454576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of PxxDY motif recognition in SH3 binding.
    Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
    J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution conformation of the antibody-bound tyrosine phosphorylation site of the nicotinic acetylcholine receptor beta-subunit in its phosphorylated and nonphosphorylated states.
    Phan-Chan-Du A; Hemmerlin C; Krikorian D; Sakarellos-Daitsiotis M; Tsikaris V; Sakarellos C; Marinou M; Thureau A; Cung MT; Tzartos SJ
    Biochemistry; 2003 Jun; 42(24):7371-80. PubMed ID: 12809492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STD and TRNOESY NMR studies for the epitope mapping of the phosphorylation motif of the oncogenic protein beta-catenin recognized by a selective monoclonal antibody.
    Megy S; Bertho G; Gharbi-Benarous J; Baleux F; Benarous R; Girault JP
    FEBS Lett; 2006 Oct; 580(22):5411-22. PubMed ID: 16996060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating transcription factor 4 and CCAAT/enhancer-binding protein-beta negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress.
    Jin HO; Seo SK; Woo SH; Kim ES; Lee HC; Yoo DH; An S; Choe TB; Lee SJ; Hong SI; Rhee CH; Kim JI; Park IC
    Free Radic Biol Med; 2009 Apr; 46(8):1158-67. PubMed ID: 19439225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model of the Interaction between the NF-κB Inhibitory Protein p100 and the E3 Ubiquitin Ligase β-TrCP based on NMR and Docking Experiments.
    Melikian M; Eluard B; Bertho G; Baud V; Evrard-Todeschi N
    J Chem Inf Model; 2017 Feb; 57(2):223-233. PubMed ID: 28004927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif.
    Jensen GA; Andersen OM; Bonvin AM; Bjerrum-Bohr I; Etzerodt M; Thøgersen HC; O'Shea C; Poulsen FM; Kragelund BB
    J Mol Biol; 2006 Sep; 362(4):700-16. PubMed ID: 16938309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.